EPISODE · May 31, 2019 · 9 MIN
Annual Meeting 2019 - The Stage IV Melanoma: What Biomarkers and Treatments Are Appropriate in the Frontline Setting?
from ASCO Education
Alexander Menzies, a Medical Oncologist and Associate Professor of Melanoma Medical Oncology at Melanoma Institute Australia (MIA), The University of Sydney, and Royal North Shore and Mater Hospitals discusses appropriate biomarkers and treatments for Stage IV Melanoma.
Embed this episode
Ready to play
Annual Meeting 2019 - The Stage IV Melanoma: What Biomarkers and Treatments Are Appropriate in the Frontline Setting?
0:00
9:49
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of ASCO Education?
This episode is 9 minutes long.
When was this ASCO Education episode published?
This episode was published on May 31, 2019.
Can I download this ASCO Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!